(Q50856082)

English

Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study.

scientific article published in February 2015

In more languages
default for all languages
No label defined

No description defined

Statements

Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study. (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit